Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery | MicrobiomeTrials← Back to trialsNCT06617897
Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2024-10-01Est. Completion: 2027-09-01
Enrollment target: 90 participants Locations- Basingstoke and North Hampshire Hospital, Basingstoke, United Kingdom
Other microbiome trials you might be interested in
Acquired Antithrombin Deficiency
The primary objective of this study is to evaluate the efficacy of two different doses of Atenativ, versus placebo, in r…
Stanford, United StatesEst. completion Mar 2028
Pregnancy ComplicationsPre-EclampsiaGrowth Retardation, Intrauterine
Pregnancy increases the risk of thrombosis. Placenta-mediated diseases are a risk factor for cardiovascular pathologies …
Nîmes, FranceEst. completion May 1, 2028